Human mismatch repair, drug-induced DNA damage, and secondary cancer.
about
MSH2 missense mutations alter cisplatin cytotoxicity and promote cisplatin-induced genome instabilityA poor imitation of a natural process: a call to reconsider the iPSC engineering techniqueExpression characteristics of FHIT, p53, BRCA2 and MLH1 in families with a history of oesophageal cancer in a region with a high incidence of oesophageal cancerStructural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activitiesDiverse small molecule inhibitors of human apurinic/apyrimidinic endonuclease APE1 identified from a screen of a large public collectionPatterns of somatic mutation in human cancer genomesComprehensive characterization of (S)GTP-binding proteins by orthogonal quantitative (S)GTP-affinity profiling and (S)GTP/GTP competition assays.DDB1-DDB2 (xeroderma pigmentosum group E) protein complex recognizes a cyclobutane pyrimidine dimer, mismatches, apurinic/apyrimidinic sites, and compound lesions in DNA.DNA mismatch-specific targeting and hypersensitivity of mismatch-repair-deficient cells to bulky rhodium(III) intercalators.Single molecule studies of DNA mismatch repair.Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivorsChemoresistance of glioblastoma cancer stem cells--much more complex than expected.Subsequent malignant neoplasms after hematopoietic cell transplantation.Molecular mechanisms of resistance and toxicity associated with platinating agents.Oncolytic viruses and DNA-repair machinery: overcoming chemoresistance of gliomas.Involvement of deoxycytidylate deaminase in the response to S(n)1-type methylation DNA damage in budding yeastMDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility.Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia.Influence of DNA damage and repair upon the risk of treatment related leukemia.Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignancies.Prolonged cell cycle response of HeLa cells to low-level alkylation exposure.Therapy-related myelodysplasia and acute myeloid leukemiaDNA damage and repair in human cancer: molecular mechanisms and contribution to therapy-related leukemias.DNA mismatch binding and antiproliferative activity of rhodium metalloinsertors.Dynamics of MutS-mismatched DNA complexes are predictive of their repair phenotypesSingle-Molecule FRET to Measure Conformational Dynamics of DNA Mismatch Repair Proteins.Selective cytotoxicity of rhodium metalloinsertors in mismatch repair-deficient cells.The homologous recombination protein RAD51D mediates the processing of 6-thioguanine lesions downstream of mismatch repair.Base excision repair dysfunction in a subgroup of patients with myelodysplastic syndrome.Hematologic adverse events associated with temozolomide.Rhodium metalloinsertor binding generates a lesion with selective cytotoxicity for mismatch repair-deficient cells.Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study.
P2860
Q24810372-C18FA724-6F75-4B0F-83B3-90C667FFD613Q26851933-BE2FDF09-6B36-4F17-AD59-0DED496FDF5CQ28252440-A66E0B15-4217-405A-B357-C1C19C8A343CQ28285134-02445061-6620-4F50-A0C6-A71FDF8FE2A4Q28484538-9F3E86B7-03C2-4BCC-B1CA-16BF244F3A8CQ29547841-71FC4273-26DB-44E2-B002-70C7B7F1B0E0Q33582587-A0F972D1-64BD-4EB6-BCDB-677B0D23C94DQ34459387-D3D68A8F-0860-41C9-A7F7-2D4E00D3EFE5Q34572718-9C570E53-AACB-459C-85CF-CFAF1DA6DA66Q35027619-3E34A0E6-3F50-480A-AC81-DB388CB064C4Q35327266-DC08FD88-A859-4402-8FC8-7051AD4830C3Q35521316-DC3FA735-7067-4838-8B1E-9EC542504C69Q35678455-E09D5419-A69C-4000-8E64-2ACBF773E4FEQ35758048-A4099450-D327-418A-89F1-A89DCD0DE429Q36668242-3DADBAD8-53C4-4846-9214-5BDF399BF2BCQ36688814-0643923D-B371-4769-8783-69D218CA67DFQ36787577-666CF02D-5498-4E68-89DD-E7CA87397864Q36835902-7FB2E780-B1B9-46ED-834F-275E5AFF74B8Q37071688-3C09758F-BE5A-42ED-8047-4B7F54F9D0D1Q37144872-EAD67B09-B339-480B-9182-EECD18EB27D5Q37331796-8B7E6612-D777-4726-9328-11C9EAE23F10Q37402657-3A774AEB-A79B-45F9-A112-F90D748CAAA0Q38052129-306D6088-6575-47FF-B6AD-C669C6CD864BQ38357043-70751E52-6EFE-448C-952D-281195B254E3Q38739461-B5D90BDA-9B6A-4BE8-969B-6F6ACEC05550Q39237485-E35C8620-0FD9-4E8F-B713-929EA031C0B4Q39439511-507025AB-46F0-425A-A3ED-98A8764E8D0AQ39612328-542579F4-212D-43D3-8A7A-83F222193719Q40039599-22AFD94D-258B-4CAE-A444-1064AB14F856Q43998950-BC1447DC-9CED-49D6-921A-9FF2078BF6C5Q45962588-BD28CC5D-1A41-49E2-BFCB-296234FB732CQ46397135-BA4846F9-87F8-46C0-BC45-728BCF663E98
P2860
Human mismatch repair, drug-induced DNA damage, and secondary cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Human mismatch repair, drug-induced DNA damage, and secondary cancer.
@ast
Human mismatch repair, drug-induced DNA damage, and secondary cancer.
@en
type
label
Human mismatch repair, drug-induced DNA damage, and secondary cancer.
@ast
Human mismatch repair, drug-induced DNA damage, and secondary cancer.
@en
prefLabel
Human mismatch repair, drug-induced DNA damage, and secondary cancer.
@ast
Human mismatch repair, drug-induced DNA damage, and secondary cancer.
@en
P1433
P1476
Human mismatch repair, drug-induced DNA damage, and secondary cancer
@en
P2093
Margherita Bignami
Peter Karran
P304
P356
10.1016/J.BIOCHI.2003.10.007
P577
2003-11-01T00:00:00Z